Xeris Biopharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/02/2025 | 10.79 M | $59.26 M | -0.25% | 7.08% |
| VANGUARD GROUP INC | 05/09/2025 | 8.11 M | $44.52 M | 2.67% | 5.32% |
| MORGAN STANLEY | 05/15/2025 | 4.29 M | $23.54 M | 49.03% | 2.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 3.41 M | $18.70 M | 1.62% | 2.23% |
| STATE STREET CORP | 05/15/2025 | 3.33 M | $18.26 M | -0.50% | 2.18% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 3.05 M | $16.76 M | 123.87% | 2.00% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 2.79 M | $15.32 M | 75.41% | 1.83% |
| ROSALIND ADVISORS, INC. | 05/14/2025 | 2.50 M | $13.70 M | -19.61% | 1.64% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 2.32 M | $12.73 M | 18.96% | 1.52% |
| 05/12/2025 | 2.23 M | $12.24 M | 100.00% | 1.46% | |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 2.16 M | $11.87 M | 3.04% | 1.42% |
| JPMORGAN CHASE & CO | 05/12/2025 | 2.11 M | $11.61 M | 102.67% | 1.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 1.84 M | $10.13 M | 301.34% | 1.21% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 1.78 M | $9.77 M | 207.76% | 1.17% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.71 M | $9.38 M | 72.38% | 1.12% |
| LEGAL & GENERAL GROUP PLC | 05/15/2025 | 1.41 M | $7.75 M | 512.50% | 0.93% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.41 M | $7.75 M | 137.63% | 0.93% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 1.35 M | $7.42 M | 100.00% | 0.89% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.35 M | $7.40 M | 61.74% | 0.88% |
| NORTHERN TRUST CORP | 05/13/2025 | 1.20 M | $6.59 M | 0.40% | 0.79% |
| KNOTT DAVID M JR | 05/12/2025 | 1.11 M | $6.09 M | 11.00% | 0.73% |
| PRUDENTIAL FINANCIAL INC | 05/13/2025 | 1.10 M | $6.03 M | 2,874.27% | 0.72% |
| INVESCO LTD. | 05/12/2025 | 1.03 M | $5.64 M | 1,387.83% | 0.67% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 946.77 K | $5.20 M | 13.39% | 0.62% |
| EAM INVESTORS, LLC | 05/13/2025 | 934.65 K | $5.13 M | 320.30% | 0.61% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 925.62 K | $5.08 M | 6,636.15% | 0.61% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 890.34 K | $4.89 M | 100.00% | 0.58% |
| UBS GROUP AG | 05/13/2025 | 863.78 K | $4.74 M | -50.20% | 0.57% |
| JANE STREET GROUP, LLC | 05/19/2025 | 820.22 K | $4.50 M | 167.83% | 0.54% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 811.61 K | $4.46 M | 100.00% | 0.53% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 756.41 K | $4.15 M | 492.80% | 0.50% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 735.09 K | $4.04 M | 10.36% | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 05/07/2025 | 730.44 K | $4.01 M | 53.79% | 0.48% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 691.72 K | $3.80 M | 100.00% | 0.45% |
| FEDERATED HERMES, INC. | 05/08/2025 | 687.78 K | $3.78 M | 36,542.67% | 0.45% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 637.78 K | $3.50 M | 494.15% | 0.42% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 600.17 K | $3.29 M | 482.69% | 0.39% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 589.47 K | $3.24 M | 244.05% | 0.39% |
| CENTERBOOK PARTNERS LP | 05/09/2025 | 472.08 K | $2.59 M | -31.59% | 0.31% |
| REDMILE GROUP, LLC | 05/15/2025 | 451.10 K | $2.48 M | 0.00% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 423.78 K | $2.33 M | 5.19% | 0.28% |
| JUMP FINANCIAL, LLC | 05/14/2025 | 423.52 K | $2.33 M | 1,371.38% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 392.10 K | $2.15 M | -15.70% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 360.32 K | $1.98 M | 11.77% | 0.24% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 344.89 K | $1.89 M | 244.85% | 0.23% |
| FMR LLC | 05/12/2025 | 311.47 K | $1.71 M | 551.97% | 0.20% |
| BARCLAYS PLC | 05/15/2025 | 280.64 K | $1.54 M | -19.27% | 0.18% |
| VOSS CAPITAL, LLC | 05/14/2025 | 275.00 K | $1.51 M | 100.00% | 0.18% |
| IHT WEALTH MANAGEMENT, LLC | 05/15/2025 | 262.81 K | $1.44 M | -2.72% | 0.17% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 255.56 K | $1.40 M | 100.00% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xeris Biopharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 219 institutional investors and hedge funds held shares of Xeris Biopharma Holdings, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 10.79 M
VANGUARD GROUP INC: 8.11 M
MORGAN STANLEY: 4.29 M
GEODE CAPITAL MANAGEMENT, LLC: 3.41 M
STATE STREET CORP: 3.33 M
D. E. Shaw & Co., Inc.: 3.05 M
56.94% of Xeris Biopharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 97.95 M shares in the last 24 months. This purchase volume represents approximately $463.31 M in transactions.